Preventive Mental Health Conference 2026
'Doing Better – Working together to promote and protect
the mental health and wellbeing of people in Australia.'
Tuesday 24 to Wednesday 25 March 2026
Novotel Parramatta
Parramatta (Sydney)/Dharug Country, NSW
#PMHC2026
Workshops
Workshops are being held on Monday 20 and Wednesday 22 June. The workshop information will continue to update as information is confirmed.
​​​
​​Workshop #1 - Reform or refute: Should Australia’s vaccine policies evolve post-COVID?
Date: Monday 20 June 2022
Start Time: 11:00am
Finish Time: 12:30pm
​
Hosted by: Medicines Australia, Sanofi, GSK, Pfizer, AstraZeneca, MSD, J&J, Seqirus & Biointelect
​
Facilitated by: Leigh Sales AM
​
Panelists consist of:
-
A/Prof. Nigel Crawford
-
Jennifer Herz
-
Dr. Brendan Shaw
-
Dr. Rod Pearce
Overview
The COVID-19 pandemic has highlighted the value of vaccines to Australians, and the importance of public health to our economic prosperity. In relation to this point, Shawview Consulting have released a White Paper entitled Valuing Vaccines: Ensuring Australia’s access to vaccines today and tomorrow. This report is an important step in encouraging dialogue and reflection about Australia’s vaccination policies and processes. The report proposes a four-point plan to enhance vaccine funding policies and ensure all Australians access innovative and best-in-class vaccines, now and in the future.
This symposium (panel discussion) provides a unique opportunity for government, industry, healthcare professionals and policy makers to engage on the 4 point plan recommendations:
-
Develop a long term strategic plan
-
Reform Australia's vaccine health technology assessment methodology
-
Reform procurement processes for NIP vaccines
-
Create a framework to develop a pandemic vaccination plan
Target Audience: Health policy makers, vaccine program makers, Government representatives, NGO/community and advocacy organisations; healthcare professionals
​
Learning Outcomes:
-
Identify key policy learnings from the COVID-19 pandemic
-
Understand challenges and barriers to current vaccine reimbursement system
-
Understand needs of future pipeline - is our system fit for purpose?
​​​
Workshop #2 - ​​Reform or refute: Should Australia’s vaccine policies evolve post-COVID?
Date: Monday 20 June 2022
Start Time: 11:00am
Finish Time: 12:30pm
​
Hosted by: Medicines Australia, Sanofi, GSK, Pfizer, AstraZeneca, MSD, J&J, Seqirus & Biointelect
​
Facilitated by: Leigh Sales AM
​
Panelists consist of:
-
A/Prof. Nigel Crawford
-
Jennifer Herz
-
Dr. Brendan Shaw
-
Dr. Rod Pearce
Overview
The COVID-19 pandemic has highlighted the value of vaccines to Australians, and the importance of public health to our economic prosperity. In relation to this point, Shawview Consulting have released a White Paper entitled Valuing Vaccines: Ensuring Australia’s access to vaccines today and tomorrow. This report is an important step in encouraging dialogue and reflection about Australia’s vaccination policies and processes. The report proposes a four-point plan to enhance vaccine funding policies and ensure all Australians access innovative and best-in-class vaccines, now and in the future.
This symposium (panel discussion) provides a unique opportunity for government, industry, healthcare professionals and policy makers to engage on the 4 point plan recommendations:
-
Develop a long term strategic plan
-
Reform Australia's vaccine health technology assessment methodology
-
Reform procurement processes for NIP vaccines
-
Create a framework to develop a pandemic vaccination plan
Target Audience: Health policy makers, vaccine program makers, Government representatives, NGO/community and advocacy organisations; healthcare professionals
​
Learning Outcomes:
-
Identify key policy learnings from the COVID-19 pandemic
-
Understand challenges and barriers to current vaccine reimbursement system
-
Understand needs of future pipeline - is our system fit for purpose?
​​​